Digital Look

Welcome to Digital Look++,
you are not logged in

Advanced Search | Company A-Z | Feedback

Indivior (INDVL)

Add To Portfolio

946.00p

Change Today:

0.41p
52 Week High: 1,448.00
52 Week Low: 577.50

Currency: UK Pounds
Shares Issued: 718.58m
Volume: 91,147

Market Cap: £6,798m

Trade now with Barclays Stockbrokers

Update - Indivior is rising today - learn to spread bet rising stocks Find out more

Indivior Overview

Indivior is a pharmaceutical company specialising in addiction treatment. Indivior was spun out of parent Reckitt Benckiser in December 2014. Adding to its Suboxone opioid addiction product, the company has a pipeline including longer-lasting 'depot' formulations, treatments for cocaine intoxication, alcohol addiction and even schizophrenia, as a psychiatric co-morbidity of addiction.

Key Personnel

CEO:	Mark Crossley
Chairman:	David E. Wheadon
Independent Non-Executive Director:	Barbara Ryan
Independent Non-Executive Director:	Daniel A. Ninivaggi
Independent Non-Executive Director:	Keith Humphreys
Independent Non-Executive Director:	Jo Le Couilliard
Independent Non-Executive Director:	Mark Stejbach
Independent Non-Executive Director:	Peter Bains
Independent Non-Executive Director:	Joe Ciaffoni
Senior Independent Director:	Juliet Thompson
Non-Executive Dir:

Contact Details

Address:	234 Bath Road, Slough, Berkshire, United Kingdom, SL1 4EE
Website:	http://www.Indivior.com

Listings

Overseas Listings:	LSE:INDV
ISIN:	GB00BRS65X63

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 5 minutes.

Indivior Market Data

Currency	UK Pounds
Share Price	946.00p
Change Today	0.41p
% Change	4.55 %
52 Week High	1,448.00
52 Week Low	577.50
Volume	91,147
Shares Issued	718.58m
Market Cap	£6,798m